ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
98,160.74
0.41%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PharmaCyte Biotech Inc (PMCB) Quote

PharmaCyte Biotech Inc

PharmaCyte Biotech Inc (PMCB)

NASDAQ
1.64
0.00
(0.00%)
Closed December 21 4:00PM
Delayed by 15 minutes
1.6391
-0.0009
(-0.05%)
After Hours: 7:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.64
Bid
1.59
Ask
20.09
Volume
13,846
1.60 Day's Range 1.649
1.39 52 Week Range 2.58
Market Cap
12.594M
Previous Close
1.64
Open
1.64
Last Trade
2085
@
1.64
Last Trade Time
Financial Volume
$ 22,392
VWAP
1.6172
Average Volume (3m)
30,224
Shares Outstanding
7,679,045
Dividend Yield
-
PE Ratio
-0.73
Earnings Per Share (EPS)
-2.24
Revenue
-
Net Profit
-17.24M

About PharmaCyte Biotech Inc

PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technol... PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Medicinal Chems,botanicl Pds
Website
ir.pharmacyte.com
Headquarters
Reno, Nevada, USA
Founded
2018
PharmaCyte Biotech Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PMCB. The last closing price for PharmaCyte Biotech was $1.64. Over the last year, PharmaCyte Biotech shares have traded in a share price range of $ 1.39 to $ 2.58.

PharmaCyte Biotech currently has 7,679,045 shares outstanding. The market capitalization of PharmaCyte Biotech is $12.59 million. PharmaCyte Biotech has a price to earnings ratio (PE ratio) of -0.73.

Ask ADVFN Intelligence (AI)

PMCB Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

December 13 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

December 04 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 13 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

August 13 2024
Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

July 29 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 17 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 17 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 17 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 17 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

May 30 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.6134969325151.631.761.668871.6629806CS
4-0.12-6.818181818181.761.811.53151191.68254852CS
12-0.14-7.865168539331.782.42291.53302241.81608521CS
26-0.46-21.90476190482.12.42291.39236991.81814046CS
52-0.62-27.43362831862.262.581.39237972.02193444CS
156-0.85-34.13654618472.493.231.391025272.35769599CS
260-1.44-46.75324675323.089.981.396291136.02056926CS

PMCB - Frequently Asked Questions (FAQ)

What is the current PharmaCyte Biotech share price?
The current share price of PharmaCyte Biotech is $ 1.64
How many PharmaCyte Biotech shares are in issue?
PharmaCyte Biotech has 7,679,045 shares in issue
What is the market cap of PharmaCyte Biotech?
The market capitalisation of PharmaCyte Biotech is USD 12.59M
What is the 1 year trading range for PharmaCyte Biotech share price?
PharmaCyte Biotech has traded in the range of $ 1.39 to $ 2.58 during the past year
What is the PE ratio of PharmaCyte Biotech?
The price to earnings ratio of PharmaCyte Biotech is -0.73
What is the reporting currency for PharmaCyte Biotech?
PharmaCyte Biotech reports financial results in USD
What is the latest annual profit for PharmaCyte Biotech?
The latest annual profit of PharmaCyte Biotech is USD -17.24M
What is the registered address of PharmaCyte Biotech?
The registered address for PharmaCyte Biotech is 401 RYLAND ST STE 200-A, RENO, NEVADA, 89502
What is the PharmaCyte Biotech website address?
The website address for PharmaCyte Biotech is ir.pharmacyte.com
Which industry sector does PharmaCyte Biotech operate in?
PharmaCyte Biotech operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
277.63M

PMCB Discussion

View Posts
$Pistol Pete$ $Pistol Pete$ 2 weeks ago
Scam company and zero product
👍️0
mick mick 2 months ago
what have you been trading ????? cybl interesting
👍️0
mick mick 2 months ago
thank for peter.
👍️0
$Pistol Pete$ $Pistol Pete$ 2 months ago
All good my Friend
👍️0
mick mick 2 months ago
HOW IS YOUR PROPERTIES DOING PETER ????? GLAD TO HEAR FROM YOU.
👍️0
$Pistol Pete$ $Pistol Pete$ 2 months ago
Thanks Mick
👍️0
mick mick 2 months ago
i see you busy here peter. you are a friend peter \\//
👍️0
$Pistol Pete$ $Pistol Pete$ 4 months ago
This scam will get below $1 by end of this year
👍️0
Monksdream Monksdream 4 months ago
PMCB new 52 week low
👍️0
$Pistol Pete$ $Pistol Pete$ 5 months ago
Still a scam
👍️0
$Pistol Pete$ $Pistol Pete$ 6 months ago
Just dump this one for a quick profit
👍️0
$Pistol Pete$ $Pistol Pete$ 7 months ago
Agreed
👍️0
Fred_Lab Fred_Lab 8 months ago
It seems pretty obvious and unfortunate that whatever resources PMCB has will just be used to support "management" until the money is gone and then they will be gone also. If their technology had any value at all we investors and potential patients would have known something by now. Very sad but true... wishing it were not.
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
Is this scam still alive?
👍️0
longboarder7892 longboarder7892 10 months ago
it should like my p+l is showing huge gains in FEMY. We took in a huge amount of shares under 1.00 and PMCB own close to 13 million shares of FEMY. Looks like all my losses from PMCB are covered already from the move in FEMY. ?So sorry to see PMCB wont be trying to use the product in the cure for PC. For those that hate the old CEO of PMCB karma has come back to him. He is not in good health. whatever goes around comes around. If this helps anyone---
PharmaCyte Biotech Inc. 10% Owner 0f FEMY 12,711,864 shares= as of now thats over a 12 million plus profit

Hey have a great day
👍️0
longboarder7892 longboarder7892 10 months ago
it should like my p+l is showing huge gains in FEMY. We took in a huge amount of shares under 1.00 and PMCB own close to 13 million shares of FEMY. Looks like all my losses from PMCB are covered already from the move in FEMY. ?So sorry to see PMCB wont be trying to use the product in the cure for PC. For those that hate the old CEO of PMCB karma has come back to him. He is not in good health. whatever goes around comes around. If this helps anyone---
PharmaCyte Biotech Inc. 10% Owner 0f FEMY 12,711,864 shares= as of now thats over a 12 million plus profit

Hey have a great day
👍️0
wuniv4ever wuniv4ever 10 months ago
If PMCB bought $5million in (FEMY) and that stock has almost tripled since they did should the charts show something a little different?
👍️0
$Pistol Pete$ $Pistol Pete$ 10 months ago
Scam…..buyers be aware
👍️0
Edward Edward 11 months ago
????? Why would i care.

I haven't owned this stock for many years.

I have no interest in PMCB.
👍️0
Edward Edward 11 months ago
??????????

Why would i care.

I haven't owned this stock for many years.

I have no interest in PMCB.
👍️0
$Pistol Pete$ $Pistol Pete$ 11 months ago
This company is dead
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Are you still holding this scam?
👍️0
Edward Edward 1 year ago
A 52 week low today.

Expected since they have no product and an unscrupulous;management.
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Paint job
👍️0
spiritthing spiritthing 1 year ago
Quote up over 20% after hours +++What is happening?
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
$2 is coming
👍️0
Edward Edward 1 year ago
Too funny-- Iroquois say in the s-3/a filing:

"Any proceeds we receive from the exercise of the Warrants will be used for general corporate purpose."

General corporate purposes??? What corporate purposes do they have, there are no operations.

Translation more money to pay themselves and their investment funds holdings to make more money.

They make the former CEO KW look like an angel, and he was a fake, misleading shareholders.
👍️0
joe_techi joe_techi 1 year ago
Risks Associated with Our Business. Our business and our ability to implement our business strategy are subject to numerous risks, mainly in that we don't do anything. If the market recognizes that doing nothing has no value it may negatively impact our share price
👍️0
Edward Edward 1 year ago
NO KIDDING!!!!!!

THAT'S WHY I DO NO NOT OWN ANY SHARES OF PMCB OR HAVE ANY INTENTION TO BUY ANY!!
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
They has zero product and just a shell to sale shares to uneducated people
👍️0
longboarder7892 longboarder7892 1 year ago
The CFO is so busy lol he couldnt file on time-Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
👍️0
joe_techi joe_techi 1 year ago
So much going on with the biz that....Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
👍️0
joe_techi joe_techi 1 year ago
They have authorized more new shares to sell to suckers so they can pay themselves for doing nothing. That is their corporate mission statement
👍️ 1
Edward Edward 1 year ago
What exactly is management doing at PMCB besides drawing money for fees as directors and as board members-- Answer is nothing.

They can't sell the company since PMCB has an unsaleable product that won't get accepted by the FDA. Any patents or rights are not worth anything since there is no product.

Current Board and Directors are set for a long time getting paid because of the cash .

Take the cash away and the assets are minuscule.
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Is this scam still alive? I thought it should be delisted by now
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
But now it is still a scam. What take over? Nothing to take over except selling shares and dump into uneducated investors on this scam company
👍️0
longboarder7892 longboarder7892 1 year ago
looks like the takeover will be happen soon. 8-10 dollars would be fine
👍️0
Edward Edward 1 year ago
????????????

I haven't owned this for years!!!!!!!!!
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
$PMCB 100% SELL

https://www.barchart.com/stocks/quotes/PMCB/opinion

Dump and run away from this scam
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Is this scam still alive? How is the trade for $2.83?
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Karma to KW. He should be in jail
👍️0
saladan2 saladan2 1 year ago
They sure are crooks.
👍️0
tjclark0551 tjclark0551 1 year ago
Hey Diana,

Thanks for the response. All I can say is Holly Smoke Screen Bat Man they're only pushing hot air. Unbelievable!!!
👍️0
Edward Edward 1 year ago
Yep.

At least KW's Scam was using Pancreatic cancer. Iroquois Scam is for a company that was shut down and doesn't have any operations.And they still increase the authorized shares. LOL.
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
All I can say is “SCAM”
👍️0
Edward Edward 1 year ago
Comical isn't it.

It's for:

the underlying shares of convertible preferred stock and warrants issued by us pursuant to the terms of that certain Securities Purchase Agreement, dated May 9, 2023, by and among PharmaCyte Biotech, Inc. and the investors named therein, in an amount equal to or in excess of 20% of our common stock outstanding before the issuance of such convertible preferred stock and warrants (including any amortization payments made to the holders of convertible preferred stock in the form of issuance of shares of common stock and upon the operation of?anti-dilution provisions contained in such convertible preferred stock and warrants);

https://www.otcmarkets.com/filing/html?id=16722179&guid=1ID-kaPm862pJth


FIRST THEY REDUCE THE OUTSTANDING AND THE ISSUE CONVERTIBLE PREFERRED SHARES AND WARRANTS! TOO FUNNY!
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Wow….more shares issue so they can dump it again

“to approve a proposed amendment to the PharmaCyte Biotech, Inc. articles of incorporation, as amended, to increase the number of authorized shares of common stock from 133,333,334 to 200,000,000; and”
👍️0
Edward Edward 1 year ago
All operations have been halted on CIAB since Iroquois took over.

There will be no IND.
👍️0
tjclark0551 tjclark0551 1 year ago
Hey, whatever happened with the IND application? I thought PMCB was refining the work and cleaning up the questions asked of them. Haven't been on here for sometime just curious if someone can give an educated guess. Thanks!
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Swing trader paradise for this scam company
👍️0

Your Recent History

NASDAQ
PMCB
PharmaCyte Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads